Acromegaly is a rare and chronic disorder characterized by excess growth hormone secretion and elevated insulin-like growth factor-1 levels, most often caused by a pituitary Adenoma.
How Acromegaly has impacted people’s lives?
Acromegaly Epidemiology Insights
How will Disease transform Acromegaly Market?
Acromegaly market size in 7MM in 2017 was USD 956.96 Million
Acromegaly Market Drivers
Acromegaly Market Barriers
Which biotechnical companies are developing Acromegaly drugs?
The emerging therapies for Acromegalytreatment that are expected to launch in the forecasted period (2020–2030) include Octreotide Capsules (Chiasma Pharma), IONIS-GHR-LRx (Ionis Pharmaceuticals), ATL1103 (Antisense Therapeutics), CAM2029 (Camurus), Veldoreotide (Strongbridge Biopharma), CRN00808 (Crinetics Pharmaceuticals), and Lanreotide PRF (Ipsen).
Media ContactCompany Name: DelveInsightContact Person: DelveInsightEmail: Send EmailPhone: +919650213330City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/